Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2018 Investor Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. TSCO
9. BE
10. SLM

Go back to Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2018 Investor Update

Ironwood Pharma (IRWD) Surges 12% Following Results/Outlook

February 13, 2019 10:02 AM EST

Ironwood Pharma (NASDAQ: IRWD) is gaining 12% in early following better-than-expected Q4 results and guidance.

... More

Ironwood Pharma (IRWD) Tops Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Mid-Point Guidance Above Consensus

February 13, 2019 7:05 AM EST

Ironwood Pharma (NASDAQ: IRWD) reported Q4 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $130.69 million versus the consensus estimate of $96.57 million.

The fourth quarter capped off a year of solid LINZESS volume growth and progress with our pipeline of seven differentiated product candidates, said... More